MVM Partners, LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), MVM Partners, LLC reported 3 stock positions worth $124.4 million. Its top holding was Paragon 28 (FNA) at 86.0% of the portfolio, followed by Mdxhealth (MDXH, 8.9%) and Optinose (5.1%). Compared with Q3 2024, it reduced 1. The biggest sale was Paragon 28 (FNA, shares −5%).
- Most Recent 13F
- Q2 2026
- Location
- BOSTON, MA
- CIK
- 0001947083
- Portfolio Value
- $124.4M (Q4 2024)
- SEC Filing
- 0001104659-25-014228 ↗ filed Feb 14, 2025
Holdings Value
Holdings 3 stocks · $124.4M
| FNA Paragon 28 Inc. | 86.01% | 10,386,145 | $107.0M | Reduce -4.6% |
| MDXH Mdxhealth | 8.88% | 4,700,457 | $11.0M | No change |
| OPTINOSE INC | 5.11% | 973,684 | $6.4M | No change |
Portfolio Sells Q3 2024 → Q4 2024
| FNA Paragon 28 Inc. | Reduce -4.6% | 86.01% | +6.99 |
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 1 | $1.9M | MDXH |
| Q1 2026 | 1 | $10.8M | MDXH |
| Q4 2025 | 1 | $16.8M | MDXH |
| Q3 2025 | 1 | $21.8M | MDXH |
| Q2 2025 | 1 | $10.3M | MDXH |
| Q1 2025 | 3 | $78.9M | FNA, OPTINOSE INC, MDXH |
| Q4 2024 | 3 | $124.4M | FNA, MDXH, OPTINOSE INC |
| Q3 2024 | 3 | $91.7M | FNA, MDXH, OPTINOSE INC |
| Q2 2024 | 3 | $99.9M | FNA, OPTINOSE INC, MDXH |
| Q1 2024 | 3 | $167.1M | FNA, OPTINOSE INC, MDXH |